Bristol-Myers Squibb Co
Stocks making the biggest moves midday: Wynn Resorts, Rocket Lab USA, Cassava Sciences and more
Check out the companies making headlines in midday trading: Bristol-Myers Squibb — The drug maker jumped more than 3% after the U.S. Food and Drug Administration approved a highly anticipated schizophrenia drug , the first novel type of treatment for the chronic mental disorder in more than seven decades. Bristol-Myers Squibb expects the twice-daily pill, […]
Read More
10 things to watch in the stock market Friday including a bullish call on Best Buy
10 things to watch Friday, Sept. 27 1. The S & P 500 was looking at a slightly higher open Friday after another record high close. The 10-year Treasury yield was finally lower following a tame August reading on the Fed’s favorite inflation gauge, the PCE price index. With just a couple trading days left […]
Read More
Stocks making the biggest moves premarket: Bristol-Myers Squibb, Costco, Super Micro Computer and more
Check out the companies making headlines in premarket trading: Bristol-Myers Squibb — The biopharmaceutical stock jumped 5.3% after the U.S. Food and Drug Administration approved Cobenfy as a treatment of schizophrenia for adults. It marks the first new type of treatment for the mental disorder in several decades. Novo Nordisk — U.S.-listed shares of the […]
Read More
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades. Schizophrenia affects how a person thinks, feels and behaves, and can cause paranoia, […]
Read More
Here’s where to invest $1 million, according to the pros
Volatility was the name of the game as markets entered the second half of the year, with stocks going through wild swings since July. The U.S. Federal Reserve made its first cut in four years — and more are expected to come. Some are also calling for investors to move out of cash with rates […]
Read More
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough. Bristol Myers Squibb, AstraZeneca, Eli Lilly and other pharmaceutical companies have spent some $10 billion on deals to acquire or work with radiopharmaceuticals makers. They’ve snapped up smaller upstarts to get their hands on technology that, while in its […]
Read More
What’s next for the Biden administration’s Medicare drug price negotiations
U.S. President Joe Biden and Vice President Kamala Harris walk out together, at an event on Medicare drug price negotiations, in Prince George’s County, Maryland, U.S., August 15, 2024. Ken Cedeno | Reuters The Biden administration on Thursday reached a milestone in Democrats’ decades-long quest to use Medicare to drive down prescription drug costs, releasing […]
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and […]
Read More
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris Kleponis | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round of Medicare drug price negotiations has come […]
Read More
Stocks making the biggest moves before the bell: McDonald’s, Tesla, Stellantis and more
Check out the companies making headlines in premarket trading. McDonald’s — Shares were down slightly in the premarket after the fast food giant reported second-quarter results that missed analyst expectations . McDonald’s also said its same-store sales — a key metric for restaurants — declined broadly. Revvity — Shares gained 6% after the life sciences […]
Read More